Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v11-FR | Version v2-FR | |
---|---|---|
Language | French | French |
Date Updated | 2020-07-08 | 2020-01-27 |
Drug Identification Number | 02049961 | 02049961 |
Brand name | TENORETIC 50/25MG TAB | TENORETIC 50/25MG TAB |
Common or Proper name | atenolol / chlorthalidone | atenolol / chlorthalidone |
Company Name | ASTRAZENECA CANADA INC | ASTRAZENECA CANADA INC |
Ingredients | CHLORTHALIDONE ATENOLOL | CHLORTHALIDONE ATENOLOL |
Strength(s) | 25MG 50MG | 25MG 50MG |
Dosage form(s) | TABLET | TABLET |
Route of administration | ORAL | ORAL |
Packaging size | 100 tablets | 100 tablets |
ATC code | C07CB | C07CB |
ATC description | BETA BLOCKING AGENTS AND OTHER DIURETICS | BETA BLOCKING AGENTS AND OTHER DIURETICS |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | 2020-04-11 | |
Actual start date | 2020-04-11 | 2020-04-01 |
Estimated end date | Unknown | |
Actual end date | 2020-04-11 | |
Shortage status | Resolved | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Company decision to discontinue product confirmed June 2020. See Discontinuation Posting. | Product to be divested to Atnahs Pharma |
Health Canada comments |